Insights
Featured Carousel
- Latest Updates on the Trump Administration
- Copyright Office Publishes Report on Copyrightability of AI-Generated Materials
- White House Announces First Steps Toward New Policies Supporting Cryptocurrencies and Digital Financial Technology
Topics Panel Section
Overview of Trump’s Executive Actions and Considerations for Potential Litigation
The Trump administration’s executive actions present unique business and legal questions for the private sector. With the administration showing no signs of slowing down, the number and size of potential legal challenges are likely to grow.
Overview of Trump’s Executive Actions and Considerations for Potential Litigation
DEI: Trump Takes Aim at Diversity Initiatives
Two executive orders require federal agencies to terminate DEI programs and mandates, and rescind long-standing affirmative action requirements for federal contractors. Increased scrutiny of DEI efforts is expected even in the private sector.
DEI: Trump Takes Aim at Diversity Initiatives
The Trump administration’s executive actions present unique business and legal questions for the private sector. With the administration showing no signs of slowing down, the number and size of potential legal challenges are likely to grow.
Overview of Trump’s Executive Actions and Considerations for Potential Litigation
Two executive orders require federal agencies to terminate DEI programs and mandates, and rescind long-standing affirmative action requirements for federal contractors. Increased scrutiny of DEI efforts is expected even in the private sector.
DEI: Trump Takes Aim at Diversity Initiatives
The executive order pausing FCPA enforcement is designed to prioritize American economic interests, but anti-bribery and corruption risks remain.
Anti-Bribery and Corruption Risks Remain Despite FCPA Enforcement Pause
RFK Jr.’s tenure as the newly confirmed secretary of the Department of Health and Human Services may lead to significant changes in U.S. health policy, including at FDA.
Under RFK Jr., US Health Policy and FDA Operations May See Major Shifts
Anti-Bribery and Corruption Risks Remain Despite FCPA Enforcement Pause
The executive order pausing FCPA enforcement is designed to prioritize American economic interests, but anti-bribery and corruption risks remain.
Anti-Bribery and Corruption Risks Remain Despite FCPA Enforcement Pause
Under RFK Jr., US Health Policy and FDA Operations May See Major Shifts
RFK Jr.’s tenure as the newly confirmed secretary of the Department of Health and Human Services may lead to significant changes in U.S. health policy, including at FDA.
Under RFK Jr., US Health Policy and FDA Operations May See Major Shifts
